Osteosarcoma of the jaws: a review of literature and a case report on synchronous multicentric osteosarcomas
© Nthumba; licensee BioMed Central Ltd. 2012
Received: 24 October 2011
Accepted: 19 September 2012
Published: 12 November 2012
In the head and neck region, osteosarcoma is the most common primary malignant bone tumor, representing 23% of total head and neck malignancies. Osteosarcomas of the jaws are nevertheless rare lesions, representing only 2 to 10% of all osteosarcomas. This report reviews a single-center histopathology experience with craniofacial osteosarcomas, and reports the management of unusually large synchronous mandibular and maxillary osteosarcomas in a patient.
Patients and methods
A search of the hospital pathology database for specimens with a histological diagnosis of osteosarcomas submitted between July 1992 and May 2011 was made. A chart review of a patient with large synchronous maxillary and mandibular osteosarcomas was performed, and is reported.
A 21-year-old African man with large maxillary and mandibular tumors under palliative care presented with increasing difficulties with eating, speech, and breathing. Surgical debulking was performed, with histology confirming synchronous osteosarcomas of the mandible and maxilla. The patient is well after one year, with no evidence of recurrence, having undergone no further treatment.
Osteosarcomas of the jaw remain enigmatic, and a number of difficulties related to their diagnosis and treatment are yet to be resolved. True synchronous multicentric osteosarcomas of the jaws are extremely rare but, like other osteosarcomas of the jaws, have a favorable outcome, and palliative resection of such lesions, though challenging, can therefore lead to an enormously improved quality of life and self-image, and may even offer the opportunity for cure.
KeywordsJaw osteosarcomas Multicentric Palliative surgery Synchronous
Osteosarcoma is the most common primary malignant bone tumor, and in the jaws represents up to 23% of total head and neck malignancies [1, 2]. Osteosarcomas of the jaws are, however, rare lesions, representing only 2 to 10% of all osteosarcomas [3–5]. Ten percent of these lesions are radiation induced. Hereditary retinoblastoma, Paget’s disease of bone, a history of fibrous dysplasia, or trauma are other factors known to predispose to the development of osteosarcomas [6–9].
Reports on osteosarcoma of the jaws from Africa are few; most reports originate from Nigeria, Kenya, and South Africa [2, 3, 8, 10–12]. Adekeye et al.  reported finding demographic characteristics in their patient population that were similar to those reported in Western literature. Chindia et al.  reported on 14 cases of jaw osteosarcomas in patients with a mean age of 30 years (one week to 50 years). The mandible was the most commonly involved bone, as in other studies [1, 2, 11]. Ogunlewe et al.  reported that osteosarcoma of the jaw constituted 0.6% of lesions of the jaws and oral cavity over a 21-year period in a Nigerian institution; the patients’ mean age was 27 years. While mandibular lesions occurred predominantly in women, their study suggested a male predisposition of maxillary lesions .
Patients with osteosarcomas of the jaw are generally 10 to 20 years older, on average, than those with osteosarcomas of long bones . They have a male to female ratio of 1:1. Studies differ as to the most commonly involved bone [1, 2, 5, 14].
As with a number of other pathologies in sub-Saharan Africa, late presentation of patients with osteosarcoma of the jaws is a common feature [3, 8, 11]. Thus, the use of adjuvant chemo-radiotherapy with surgical extirpation does not appear to affect outcomes, primarily as the result of late presentation [3, 8].
The primary presenting complaints are pain, swelling, paresthesia, and ulceration . Osteosarcomas of the jaws have a different biological behavior from that of osteosarcomas of the long bones, with a lower incidence of metastases and a much better prognosis. This conclusion is based on findings from many case reports and small case series [4, 15, 16]. Studies on larger cohorts of patients with osteosarcomas of the jaw have suggested a prognosis equivalent to that of long-bone osteosarcomas, which is therefore poorer than previously thought; a conclusion that is not widely accepted at the present time [17, 18].
Unusual presentations of osteosarcomas of the jaws, the continuing challenges in establishing both radiological and histological diagnosis, and controversies in treatment and prognosis are the reasons for presenting this case report and literature review.
Patients and methods
A search of the hospital pathology database for specimens with a histological diagnosis of osteosarcomas submitted between July 1992 and May 2011 was made. A chart review of a patient with large maxillary and mandibular tumors found to be osteosarcomas was drawn up, and the results presented. This study did not require the approval of the hospital ethics committee because it is a retrospective or chart review study.
A total of 235 specimens submitted between July 1992 and May 2011 to the AIC Kijabe Hospital pathology department were reported histologically as osteosarcomas. Of six patients with osteosarcomas of the craniofacial region, five had jaw tumors. There were two men and three women, with a mean age of 29.5 years. Jaw osteosarcomas represented 2.1% of all osteosarcomas recorded during the study period.
On presentation to the author’s institution, palliative debulking was offered, with the hope of improving the quality of life postoperatively.
At the time of discharge from hospital, the patient could feed himself, speak intelligibly, and breathe comfortably. He remains well one year after the operation.
Osteosarcomas of the jaws are challenging lesions in many ways. These tumors are very deforming: they occur in the anatomical region that defines an individual the most, and therefore any deformity here affects the individual in many areas of life. Nothing is more psychologically depressing than rejection by one’s own family, as was the status of the patient presented here. Surgical resection of these tumors is another challenge: adequate resection of these tumors is difficult, especially of the maxilla, because of the complexity of the anatomy, and the resultant defect. Defect reconstruction is a further challenge: facial height and width must be maintained or reconstructed. While the potential for complications in the resection of both the mandible and maxilla is significant, the potential gain even for a purely palliative excision is great, given the cruelty of death from starvation and suffocation that the patient would otherwise have had to face.
The difficulties with histological and radiological diagnosis of osteosarcomas of the jaw are well documented [3, 4, 16, 19–21]. In the case presented here, a provisional diagnosis of juvenile ossifying fibroma was initially entertained, with international consultations leading to a consensus diagnosis of osteosarcoma of both the mandible and the maxilla.
The ‘sunburst’ appearance, the classic radiologic appearance of long-bone osteosarcomas, is not pathognomonic for jaw osteosarcomas. Indeed, the radiologic appearance of jaw osteosarcomas depends on the interplay of three processes: bone formation and mineralization, bone destruction, and periosteal bone formation. Radiologically, the lesions may range from predominantly radiolucent to radio-opaque lesions, with any combinations thereof, depending on the degree of ossification . Plain radiographs and CT scans may be used to define the tumor extent and may thus aid in deciding on resectability, while a chest radiograph or CT scan may be used to detect lung metastasis.
While the initial aim of the surgery was palliative debulking, the resection margins obtained gave hope for the possibility of a cure, especially if adjuvant radiotherapy could be accessed in good time, before any recurrence.
Some authors have suggested that tumor size, location, and histologic grade are the main prognostic factors, although this has been disputed , with others stating that tumor size does not appear to be of prognostic value . Early diagnosis and adequate surgical resection are essential for survival, with control of local spread assuring short-term survival. Where adequate resection is possible, surgery alone is adequate, while adjuvant therapy should be considered where surgical margins are inadequate [3, 9]. Some authors have suggested that craniofacial osteosarcomas are high-grade tumors, which would suggest a poor outcome in general, but this is not borne out in the general literature, and may be rather an expression of a population-specific variable [7, 16]. Only 9% of craniofacial osteosarcomas in a study by Jasnau et al.  were high-grade tumors.
Daffner et al.  reported an unusually aggressive osteosarcoma of the mandible, with widespread systemic metastases and death within four months of diagnosis. In contrast, many authors have found most jaw osteosarcomas to be well differentiated [23, 25].
Because of easier resectability, and the ability to obtain negative surgical margins, mandibular osteosarcomas have a better prognosis than maxillary tumors . Granowski-LeCornu et al. confirmed a poorer outcome for maxillary tumors, related to the difficulty in obtaining adequate resection margins, leading to increased incidence of local recurrence, residual disease, and death. Long-term survival is dependent on such variables as local recurrence, intracranial invasion, and distant spread.
Thus, wide surgical resection forms the most important intervention in the management of osteosarcomas of the jaws, with chemotherapy and irradiation being adjuvant modes, or primary modes in instances of palliation for unresectable lesions .
While adjuvant chemotherapy may improve early survival, neither chemotherapy nor radiotherapy appears to impact long-term survival. Because positive surgical margins are associated with poor prognosis, some authors have shown that the use of multimodal therapy may significantly reduce rates of local recurrence, and thereby improve survival [14, 18, 19, 27].
The likelihood of cure in osteosarcomas of the jaws has been estimated at 60% to 70% . Nevertheless, palliative resection, when feasible, even for extensive tumors such as the one reported by the current author, offers the potential for an immediate improvement in the quality of life, including the ability to re-integrate with society, feed, and regain speech and a highly increased degree of self-worth and acceptance.
Multicentric osteosarcomas, defined as lesions present in more than one bone, typically in the absence of pulmonary or other visceral metastases, represent 1 to 2% of all osteosarcomas. They may be synchronous (multiple tumor foci within 5 months of initial presentation) or metachronous (multiple tumor foci 5 months after initial presentation) [24,28,]. Multicentric osteosarcoma cell lines have increased invasiveness and metastatic ability, as well as an affinity for bone; additionally, they have a uniformly poor response to multimodal therapy. Synchronous osteosarcomas (dominant lesions found with smaller synchronous lesions), are associated with a poorer prognosis, because of rapid disease progression and death . The debate as to whether multicentric osteosarcomas represent primarily metastatic disease or multiple primaries is unsettled [28, 29]. Another entity found in up to 10% of osteosarcomas is ‘skip’ metastases, where a second focus of osteosarcoma is found in the same bone or in an adjacent bone across a joint [29, 30].
It is instructive that, with the exception of a few reports [4, 24], almost all the conclusions on the behavior of multicentric osteosarcomas are based on long-bone tumors, which are known to differ significantly in their biological behavior from that of tumors of the jaws, and cannot, therefore, be representative of multicentric osteosarcomas of the jaws [28–30]. Indeed, to date, there are only four reports of multicentric osteosarcomas involving the jawbones in the English literature [31–34].
Behere and Lele  reported on a 16-year-old girl found to have a mandibular osteosarcoma and multiple synchronous skeletal lesions. Stroncek et al.  similarly reported on a 15-year-old girl with mandibular and ilium osteosarcomas, and postmortem pulmonary metastases. They hypothesized that the mandibular tumor was metastatic from the ilium. Ohba et al.  reported on a 17-year-old girl who presented with mandibular metastasis from an osteosarcoma of the fibula; she subsequently developed systemic metastases. Zhang et al.  reported on an 18-year-old girl with synchronous osteosarcoma lesions in the mandible and maxilla. Of all the cases of multicentric jaws osteosarcomas in English literature to date, three represent obvious systemic metastatic disease [31–33], with only one  involving only the jaws. Interestingly, all the four cases reported involved teenage girls [31–34].
Thus, the current case report represents the first male patient with synchronous jaw osteosarcomas, and the only one from sub-Saharan Africa. The absence of other lesions and the clinical and radiological presentation in the current case lends credence for the synchronous multicentric theory in the evolution of these osteosarcomas. These lesions are most likely to have developed independently in two different anatomical sites, in the same individual. Their size, and the time to surgical excision, is evidence of the different biological behavior exhibited by these tumors, and the better prognosis associated with jaw osteosarcomas when compared with long-bone osteosarcomas. Thus the report by Zhang et al.  and this report serve as evidence that multicentric jaw osteosarcomas do not necessarily always represent a continuum of metastatic osteosarcoma disease, as proposed by some authors [24, 28]. Indeed, one may conclude that the older three reports on multicentric jaw tumors represent purely metastatic disease, from long bones in a disease known to be aggressive, and should not, therefore, be used as evidence of the process of evolution of jaw osteosarcomas [31–33].
Evidence from most studies has shown that jaw osteosarcomas rarely metastasize, lending further weight to the argument that apparently multicentric osteosarcomas involving the jaws and the appendicular skeleton are more likely to be metastatic from the long bones [24, 28, 31–33].
All authors appreciate the different behavioral patterns of gnathic osteosarcomas compared with long-bone osteosarcomas. It is, therefore, entirely possible that well-differentiated osteosarcomas represent an entirely different entity, one that is related to but is not an actual osteosarcoma. Such an entity would explain the difficulties abounding in the literature on histological and radiological diagnosis, differences in response to treatment, and rarity of metastatic disease with, therefore, a more favorable prognosis of gnathic osteosarcomas . Perhaps the time has come for histopathologists to re-examine diagnostic criteria for jaw osteosarcomas.
Jaw osteosarcomas remain enigmatic in many ways, and a number of difficulties related to their diagnosis and treatment are yet to be resolved. True synchronous multicentric osteosarcomas of the jaws are extremely rare but, like other osteosarcomas of the jaws, these have a favorable outcome, and palliative resection of such lesions though challenging, can therefore lead to an enormously improved quality of life and self-image, and may even offer the opportunity for cure.
Written informed consent was obtained from the patient for the publication of this paper and any accompanying images. A release letter was signed by the patient (thumbprint) permitting publication of features that may lead to his recognition by anyone who knows him, and has been made available to the Editor-in-Chief of this journal.
The author is grateful to Dr. Ancent Nzioka of the Department of Pathology, AIC Kijabe Hospital, for help with the slides.
- Chindia ML, Swaleh SM, Godiah PM: Sarcomas of the head and neck at Kenyatta National Hospital. East Afr Med J 2000, 77:256–259.PubMed
- Omololu AB, Ogunbiyi JO, Ogunlade SO, Alonge TO, Adebisi A, Akang EE: Primary malignant bone tumour in a tropical African University teaching hospital. West Afr J Med 2002, 21:291–293.PubMed
- Adekeye EO, Chau KK, Edwards MB, Williams HK: Osteosarcoma of the jaws - a series from Kaduna, Nigeria. Int J Oral Maxillofac Surg 1987, 16:205–213.PubMedView Article
- Amaral MB, Buchholz I, Freire-Maia B, Reher P, de Souza PE, Marigo Hde A, Martins CR, Horta MC: Advanced osteosarcoma of the maxilla: a case report. Med Oral Patol Oral Cir Bucal 2008, 13:E492-E495.PubMed
- Jasnau S, Meyer U, Potratz J, Jundt G, Kevric M, Joos UK, Jürgens H, Bielack SS: Cooperative Osteosarcoma Study Group COSS: Craniofacial osteosarcoma. Experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol 2008, 44:286–294.PubMedView Article
- Shao Z, He Y, Wang L, Hu H, Shi H: Computed tomography findings in radiation - induced osteosarcoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109:e88-e94.PubMedView Article
- Mendenhall WM, Fernandes R, Werning JW, Vaysberg M, Malyapa RS, Mendenhall NP: Head and neck osteosarcoma. Am J Otolaryngol 2011, 32:597–600.PubMedView Article
- Ogunlewe MO, Ajayi OF, Adeyemo WL, Ladeinde AL, James O: Osteogenic sarcoma of the jaw bones: a single institution experience over a 21-year period. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 101:76–81.PubMedView Article
- van Es RJ, Keus RB, van der Waal I, Koole R, Vermey A: Osteosarcoma of the ts. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg 1997, 26:191–197.PubMedView Article
- Chukwuneke FN, Agwuna K, Anyanechi CE: Radiological interpretation of osteosarcoma of the jaw: its relevance in clinical management. Journal of College of Medicine 2008, 13:39–43.
- Chindia ML, Guthua SW, Awange DO, Wakoli KA: Osteosarcoma of the maxillofacial bones in Kenyans. J Craniomaxillofac Surg 1998, 26:98–101.PubMedView Article
- Khammissa RA, Mabusela M, Wood NH, Bouckaert M, Meyerov R, Lemmer J, Feller L: Osteosarcoma of the jaw. A brief review and a case report. SADJ 2009, 64:220–221.PubMed
- Kassir RR, Rassekh CH, Kinsella JB, Segas J, Carrau RL, Hokanson JA: Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope 1997, 107:56–61.PubMedView Article
- Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM: Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer 2009, 115:3262–3270.PubMedView Article
- Kumaravelu C, Kumar DS, Chakravarthy C, Kumar RVK, Rajasekhar MG, Reddy GC, Reddy KS: Chondroblastic osteosarcoma of maxilla: a case report and review of literature. J Maxillofac Oral Surg 2009, 8:290–293.PubMedView Article
- Padilla RJ, Murrah VA: The spectrum of gnathic osteosarcoma: caveats for the clinician and the pathologist. Head Neck Pathol 2011, 5:92–99.PubMedView Article
- Delgado R, Maafs E, Alfeiran A, Mohar A, Barrera JL, Zinser J, Beltran A: Osteosarcoma of the jaw. Head Neck 1994, 16:246–252.PubMedView Article
- Canadian Society of Otolaryngology-Head and Neck Surgery Oncology Study Group: Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980–2000). J Otolaryngol 2004, 33:139–144.View Article
- Desai D, Pandith S, Jeergal PA, Arathi K, Saini R: Fibroblastic variant of osteosarcoma: a challenge in diagnosis & management. Open Dent J 2010, 4:211–217.PubMedView Article
- Nakayama E, Sugiura K, Kobayashi I, Oobu K, Ishibashi H, Kanda S: The association between the computed tomography findings, histologic features, and outcome of osteosarcoma of the jaw. J Oral Maxillofac Surg 2005, 63:311–318.PubMedView Article
- Cavalcanti MGP, Ruprecht A, Yang J: Radiological findings in an unusual osteosarcoma in the maxilla. Dentomaxillofac Radiol 2000, 29:180–184.PubMedView Article
- Granados-Garcia M, Luna-Ortiz K, Castillo-Oliva HA, Villavicencio-Valencia V, Herrera-Gómez A, Mosqueda-Taylor A, Aguilar-Ponce JL, Poitevin-Chacón A: Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma. Oral Oncol 2006, 42:172–176.PubMedView Article
- Altuwairgi O, Papageorge MB, Karp DD: Maxillary chondroblastic sarcoma: presentation of two cases and a literature review. J Oral Maxillofac Surg 1996, 54:1357–1364.PubMedView Article
- Daffner RH, Fox KR, Galey K: Fibroblastic osteosarcoma of the mandible. Skeletal Radiol 2002, 31:107–111.PubMedView Article
- Clark JL, Unni KK, Dahlin DC, Devine KD: Osteosarcoma of the jaws. Cancer 1983, 51:2311–2316.PubMedView Article
- Granowski-LeCornu M, Chuang SK, Kaban LB, August M: Osteosarcoma of the jaws: factors influencing prognosis. J Oral Maxillofac Surg 2011, 69:2368–2375.PubMedView Article
- Smith RB, Apostolakis LW, Karnell LH, Koch BB, Robinson RA, Zhen W, Menck HR, Hoffman HT: National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 2003, 98:1670–1680.PubMedView Article
- Yamamoto Y, Yamamoto N, Tajima K, Ohno A, Washimi Y, Ishimura D, Washimi O, Yamada H: Characterization of human multicentric osteosarcoma using newly established cells derived from multicentric osteosarcoma. J Cancer Res Clin Oncol 2011, 137:423–433.PubMedView Article
- Daffner RH, Kennedy SL, Fox KR, Crowley JJ, Sauser DD, Cooperstein LA: Synchronous multicentric osteosarcoma: the case for metastases. Skeletal Radiol 1997, 26:569–578.PubMedView Article
- Enneking WF, Kagan A: “Skip” metastases in osteosarcoma. Cancer 1975, 36:2192–2205.PubMedView Article
- Behere R, Lele S: Synchronous osteosarcoma of mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:e45-e49.PubMedView Article
- Stroncek GG, Dahl EC, Fonseca RJ, Benda JA: Multiosseous osteosarcoma involving the mandible: metastatic or multicentric? Oral Surg Oral Med Oral Pathol 1981, 52:271–276.PubMedView Article
- Ohba T, Katayama H, Nakagawa E, Takeda N: Mandibular metastasis of osteogenic sarcoma. Report of a case. Oral Surg Oral Med Oral Pathol 1975, 39:821–825.
- Zhang Q, Li Y, Gao N, Huang Y, Li LJ: Synchronous multicentric osteosarcoma involving mandible and maxillas. Int J Oral Maxillofac Surg 2011, 40:446–449.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.